Portage Biotech (PRTG) announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a ...

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual ...

Stay updated on market trends for PRTG. Portage Biotech stock is trading higher after the company announced it signed a letter of intent with Immunova for the potential sale of its subsidiary.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

The US IT security authority CISA warns of recently observed attacks in the wild on vulnerabilities in Linux, Apache OFBiz, Microsoft's .Net framework and Paessler PRTG. IT managers should ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...